Oral Oncology
Volume 46, Issue 9 , Pages 667-671 , September 2010

Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma

  • Maximilian Moergel

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University of Mainz, Medical Center, Augustusplatz 2, 55131 Mainz, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Oral and Maxillofacial Surgery, Johannes Gutenberg-University, Medical Center, Augustusplatz 2, 55131 Mainz, Rheinland-Pfalz, Germany. Tel.: +49 6131 175459; fax: +49 6131 176602.
    • ,
  • Eva Abt

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University of Mainz, Medical Center, Augustusplatz 2, 55131 Mainz, Germany
    • ,
  • Marcus Stockinger

      Affiliations

    • Department of Radiation Oncology, University of Mainz, Medical Center, Langenbeckstr. 1, 55101 Mainz, Germany
    • ,
  • Martin Kunkel

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University of Bochum Medical Center, Knappschaftskrankenhaus Bochum Langendreer, In der Schonau 23-25, 44892 Bochum, Germany

Received 29 April 2010 ,Revised 24 June 2010 ,Accepted 24 June 2010.

References 

  1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, et al. p63, a p53 Homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Molecular Cell. 1998;2:305–316
  2. Mills A, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Letters to Nature. 1999;22(4):708–713
  3. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR, et al. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Molecular Cell. 2006;24(17):593–602
  4. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T. Search for mutations and examination of allelic expression imbalance of the p73 gene at one p36.33 in human lung cancers. Cancer Res. 1998;7(58):1380–1383
  5. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med. 1998;4(7):839–843
  6. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002;4(416):560–564
  7. Senoo M, Manis JP, Alt FW, McKeon F. p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. Cancer Cell. 2004;6(1):85–89
  8. Chen YK, Hsue SS, Lin LM. Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. Oral Dis. 2003;9(5):235–240
  9. Pellegrini G, Dell’ambra E, Molisano O, Martinelli E, Fantozzi I, Bondanza S, et al. p63 Identifies keratinocyte stem cells. Proc Natl Acad Sci USA. 2001;13(98):3156–3161
  10. Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, et al. DeltaNp63 expression is associated with poor survival in ovarian cancer. Ann Oncol. 2008;19(3):501–507
  11. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, et al. P63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Human Pathol. 2005;36(2):187–194
  12. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, et al. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 2005;24(13):2458–2471
  13. Battifora H. Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol. 1991;96:669–671
  14. Mohr C, Bohndorf W, Gremmel H. Preoperative radiochemotherapy and radical surgery of advanced head and neck cancers–results of a prospective, multicenter DOSAK study. Recent Results Cancer REs. 1994;134:155–163
  15. Bier J. Definitionen zum radikalchirurgischenVorgehen bei Plattenepithelkarzinomen der Mundhöhle. Dtsch Z Mund Kiefer GesichtsChir. 1982;6:369–372
  16. Wittekind C, Wagner G. TNM-Klassifikation maligner Tumoren. fifth. Berlin: Springer; 1997;p. 213
  17. Mann HB, Whitney DR. On a test whether one or two random variables is stochastically larger than the other. Annals Math Stat. 1947;18:50
  18. Kruskal WH, Wallis WA. Use of ranks in one criterion variance analysis. J Amer Stat Assoc. 1952;57:583–621
  19. Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Amer Stat Assoc. 1958;53:457–481
  20. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Society-Series B. 1972;34:187–202
  21. Mignogna MD, Fedele S, Lo Russo L. The world cancer report and the burdon of oral cancer. Eur J Cancer Prev. 2004;13(2):139–142
  22. Suntharalingam M, Haas ML, Van Echo DA, Haddad R, Jacobs MC, Levy S, et al. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2001;91(3):548–554
  23. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer. 2008;112(3):535–543
  24. Gourin CG, Conger BT, Porubsky ES, Sheils WC, Bilodeau PA, Coleman TA. The effect of occult nodal metastasis on survival and regional control in patients with head and neck squamous cell carcinoma. Laryngoscope. 2008;118(7):1191–1194
  25. Stewart FA, Dörr W. Milestones in normal tissue radiation biology over the past 50 years: from clonogenic cell survival to cytokine networks and back to stem cell recovery. Int J Radiat Biol. 2009;85(7):574–586
  26. Lo Muzio L, Campisi G, Farina A, Rubini C, Pastore L, Giannone N, et al. Effect of p63 expression on survival in oral squamous cell carcinoma. Cancer Invest. 2007;25(6):464–469
  27. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 Mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell. 2006;9(1):45–56
  28. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004;2(7):371–386
  29. Muzio L, Campisi G, Farina A, Rubini C, Pastore L, Giannone N, et al. Effect of p63 expression on survival in oral squamous cell carcinoma. Cancer Invest. 2007;25(6):464–469
  30. Asioli S, Righi A, Volante M, Eusebi V, Bussolati G. P63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer. 2007;110(3):640–647
  31. Narahashi T, Niki T, Wang T, Goto A, Matsubara D, Funata N, et al. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. Histopathology. 2006;49(4):349–357
  32. Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, et al. DeltaNp63 expression is associated with poor survival in ovarian cancer. Ann Oncol. 2008;19(3):501–507
  33. Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, et al. Ph III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol. 2006;24(18):2873–2878
  34. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368(9538):843–854
  35. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA six and seven randomised controlled trial. Lancet. 2003;362(9388):933–940
  36. Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR. CRA- down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res. 2000;60(15):4016–4020
  37. Westfall MD, Pietenpol JA. p63: Molecular complexity in development and cancer. Carcinogenesis. 2004;25(6):857–864

PII: S1368-8375(10)00196-X

doi: 10.1016/j.oraloncology.2010.06.012

Oral Oncology
Volume 46, Issue 9 , Pages 667-671 , September 2010

Article Tools

* Image Usage & Resolution